Previous study demonstrated that miR-9-5p was upregulated in serous ovarian cancer, and overexpression of miR-9-5p could promote tumor metastasis via targeting E-cadherin (Zhou et al., 2017a). The gene discussed is CDH1; the disease is ovarian serous adenocarcinoma.